← SynDRA
PELITINIB
SynDRA canonical compound SYN0020717 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
| Primary target(s) | EGFR | ERBB2 |
| Mechanism of action | EGFR inhibitor |
All known targets
Mechanisms of action (all sources)
- EGFR INHIBITOR
- Epidermal growth factor receptor erbB1 inhibitor
- EGFR MODULATOR
Drug classes
- Antineoplastic Agents
- Protein Kinase Inhibitors
Cross-references
Synonyms
- EKB-569
- WAY-EKB-569
- EKI-569
- EKB 569
- Pelitinib (EKB-569)
- (E)-N-(4-(3-chloro-4-fluorophenylamino)-3-cyano-7-ethoxyquinolin-6-yl)-4-(dimethylamino)but-2-enamide
- (E)-N-(4-((3-Chloro-4-fluorophenyl)amino)-3-cyano-7-ethoxyquinolin-6-yl)-4-(dimethylamino)but-2-enamide
- X5DWL380Z6
- (2E)-N-(4-((3-chloro-4-fluorophenyl)amino)-3-cyano-7-ethoxy-6-quinolinyl)-4-(dimethylamino)-2-butenamide
- (2E)-N-{4-[(3-chloro-4-fluorophenyl)amino]-3-cyano-7-ethoxyquinolin-6-yl}-4-(dimethylamino)but-2-enamide
- CHEBI:38927
- Pelitinib (EKB-569; WAY-EKB 569)
- (E)-N-[4-(3-chloro-4-fluoroanilino)-3-cyano-7-ethoxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide
- MFCD09837868
- (E)-N-[4-(3-chloro-4-fluoroanilino)-3-cyano-7-ethoxy-6-quinolinyl]-4-(dimethylamino)-2-butenamide
- (E)-N-[4-[(3-chloranyl-4-fluoranyl-phenyl)amino]-3-cyano-7-ethoxy-quinolin-6-yl]-4-(dimethylamino)but-2-enamide
- 2-Butenamide, N-(4-((3-chloro-4-fluorophenyl)amino)-3-cyano-7-ethoxy-6-quinolinyl)-4-(dimethylamino)-, (2E)-
- Pelitinib [USAN]
- EKI 569
- Pelitinib [USAN:INN]
- UNII-X5DWL380Z6
- EKB569
- (2E)-N-(4-((3-Chloro-4-fluorophenyl)amino)-3-cyano-7-ethoxyquinolin-6-yl)-4-(dimethylamino)but-2-enamide
- (2e)-n-[4-[(3-chloro-4-fluorophenyl)amino]-3-cyano-7-ethoxy-6-quinolinyl]-4-(dimethylamino)-2-butenamide
- 93J
- PELITINIB [INN]
- Pelitinib (USAN/INN)
- Pelitinib - EKB-569
- 2-Butenamide, (E)-,
- PELITINIB [WHO-DD]
- SCHEMBL93756
- SCHEMBL93757
- MLS006010062
- CHEMBL607707
- GTPL7644
- BDBM31090
- cid_6445562
- EX-A061
- BCPP000118
Look up PELITINIB in the interactive SynDRA portal →